Condition: Type 1 Diabetes · Obesity · Sponsor: Heba M. Ismail
Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for complications. The proposed study is relevant to public health because it helps us understand the role of the gut microbiome in disease pathophysiology in T1D youth with overweight and obesity as well as potential mechanisms to modify disease.
This description comes directly from the study's public registry record.
Heba M Ismail · 317-274-2114 · heismail@iu.edu
HI Team · 317-274-2114 · hiteam@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University School of Medicine | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05414409